Chronix Biomedical provides update on studies and presentations
Data from pilot studies using Chronix’s CNI test submitted for presentation at a high profile scientific meeting and for publication in a prominent peer-reviewed journalSan Jose, CA, USA and Göttingen, Germany (27 February 2016) – Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, is pleased to report the successful outcome of two pilot studies